UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US Practice

The American journal of cardiology, 2016-05, Vol.117 (9), p.1439-1443

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

Journal of the American College of Cardiology, 2017-10, Vol.70 (15), p.1846-1857

2017

Link zum Volltext

Verfügbarkeit prüfen

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry

Critical care (London, England), 2023-06, Vol.27 (1), p.243-243, Article 243

2023

Link zum Volltext

Verfügbarkeit prüfen

The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences

Critical care research and practice, 2021, Vol.2021, p.7769516-10

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of hemoadsorption in cardiac surgery - a systematic review

BMC cardiovascular disorders, 2024-05, Vol.24 (1), p.258-258

2024

Link zum Volltext

Verfügbarkeit prüfen

Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

Journal of the American College of Cardiology, 2016-12, Vol.68 (24), p.2608-2618

2016

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy

Critical care explorations, 2022-05, Vol.4 (5), p.e0688-e0688

2022

Link zum Volltext

Verfügbarkeit prüfen

Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance

Thrombosis and haemostasis, 2002-11, Vol.88 (5), p.711

2002

Link zum Volltext

Verfügbarkeit prüfen

Association between periodontal disease and vulnerable plaque morphology in patients undergoing carotid endarterectomy

International journal of cardiology. Heart & vasculature, 2020-10, Vol.30, p.100601-100601, Article 100601

2020

Link zum Volltext

Verfügbarkeit prüfen

Bivalirudin Started during Emergency Transport for Primary PCI

The New England journal of medicine, 2013-12, Vol.369 (23), p.2207-2217

2013

Link zum Volltext

Verfügbarkeit prüfen

Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials

European heart journal. Acute cardiovascular care, 2017-10, Vol.6 (7), p.659-665

2017

Link zum Volltext

Verfügbarkeit prüfen

Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding

Journal of the American College of Cardiology, 2016-02, Vol.67 (5), p.596-598

2016

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding: The HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)

Journal of the American College of Cardiology, 2014-01, Vol.63 (1), p.15-20

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding

Journal of the American College of Cardiology, 2014-01, Vol.63 (1), p.15-20

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention – Insights from the CHAMPION program

American heart journal plus, 2021-09, Vol.9, p.100043-100043, Article 100043

2021

Link zum Volltext

Verfügbarkeit prüfen

Heparin or bivalirudin for non‐primary PCI: Beware of neat and simple answers

Catheterization and cardiovascular interventions, 2017-09, Vol.90 (3), p.378-379

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

Clinical pharmacokinetics, 2022-04, Vol.61 (4), p.465-479

2022

Link zum Volltext

Verfügbarkeit prüfen

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement

Journal of the American College of Cardiology, 2015-12, Vol.66 (25), p.2860-2868

2015

Link zum Volltext

Verfügbarkeit prüfen

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial

Journal of the American College of Cardiology, 2015-12, Vol.66 (25), p.2860-2868

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial

European heart journal, 2018-12, Vol.39 (46), p.4112-4121

2018

Link zum Volltext

Verfügbarkeit prüfen

Bivalirudin versus heparin for peripheral vascular intervention: You get what you pay for

Catheterization and cardiovascular interventions, 2017-02, Vol.89 (3), p.414-415

2017

Link zum Volltext

Verfügbarkeit prüfen

Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding

European heart journal, 2023-05, Vol.44 (20), p.1780-1794

2023

Link zum Volltext

Verfügbarkeit prüfen

Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study

Journal of the American College of Cardiology, 2016-08, Vol.68 (6), p.589-599

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(133)

Sprache

Englisch
(133)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US Practice

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry

The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences

The role of hemoadsorption in cardiac surgery - a systematic review

Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy

Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance

Association between periodontal disease and vulnerable plaque morphology in patients undergoing carotid endarterectomy

Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials

Bivalirudin Started during Emergency Transport for Primary PCI

Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial

Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials

Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding

Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding: The HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)

Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding

Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention – Insights from the CHAMPION program

Heparin or bivalirudin for non‐primary PCI: Beware of neat and simple answers

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial

Bivalirudin versus heparin for peripheral vascular intervention: You get what you pay for

Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding

Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study

Suchergebnisse filtern